Summary
Updated Aug 31, 2026
Jason Aryeh is Director of Orchestra BioMed Holdings, Inc. (OBIO). 10 SEC Form 4 filings on record going back to 2024, most recently on 25 June 2026. Most recent open-market trade: sold $1.12M of LGND on 12 June 2026. Lifetime open-market purchases: $40K. Lifetime open-market sales: $2.96M. Historical track record: 4/5 stars across 3 tracked purchases.
Recent Transactions
13Every recent SEC Form 4 transaction Jason Aryeh has reported, most recent first.
Track Record
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realized performance after each tracked open-market purchase.
| Metric | Value |
|---|---|
| InsiderAlpha rating | ★★★★☆ (4/5) |
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 67% |
| 90-day win rate | 100% |
| Avg 5-day return | +1.97% |
| Avg 30-day return | +21.26% |
| Avg 90-day return | +38.70% |
| Best 30-day return | +59.84% |
Trading Pattern
InsiderAlpha's records for Jason Aryeh go back to 2024: 10 primary Form 4 filings, an average of 3.3 per year. The typical open-market purchase is $13K (3 buys totaling $40K). The largest single buy on record is $35K of OBIO in 2026. Sales side: 5 recorded sales totaling $2.96M, so the filing history runs sell-heavy by dollar value. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Jason Aryeh files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Octavio Espinoza - $13.03M of LGND open-market activity in the last 12 months
- Andrew Reardon - $7.34M of LGND open-market activity in the last 12 months
- Jason Haas - $3.74M of LGND open-market activity in the last 12 months
- John L. Lamattina - $2.44M of LGND open-market activity in the last 12 months
- Nancy Ryan Gray - $1.35M of LGND open-market activity in the last 12 months
- John W. Kozarich - $1.18M of LGND open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Jason Aryeh?
Jason Aryeh is a corporate insider, tracked as Director of Orchestra BioMed Holdings, Inc. (OBIO). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jason Aryeh submitted recently?
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Has Jason Aryeh been buying or selling stock?
Recorded transactions: 3 open-market purchases ($40K) and 5 open-market sales ($2.96M) across all tracked filings.
How accurate is Jason Aryeh's historical track record?
Across 3 tracked purchases, Jason Aryeh averaged +21.3% avg 30-day return with a 67% 30-day win rate. InsiderAlpha rates the track record at 4/5 stars.
Where can I see all of Jason Aryeh's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Jason Aryeh and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial